Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul S Freemont

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Emerging Topics in Life Sciences|February 1, 2021
Synthetic biology industry: data-driven design is creating new opportunities in biotechnologyPaul S Freemont
The Biochemical Journal|August 19, 2017
The AAA+ ATPase p97, a cellular multitoolLasse Stach, Paul S Freemont
Synthetic Biology (Oxford, England)|October 29, 2021
Biofoundries are a nucleating hub for industrial translationTabasum Farzaneh, Paul S Freemont
GEN Biotechnology|January 16, 2023
Simple Low-Cost Production of DNA MS2 Virus-Like Particles As Molecular Diagnostic ControlsMichael A Crone, Paul S Freemont
Nature Communications|January 22, 2022
Pandemic preparedness: synthetic biology and publicly funded biofoundries can rapidly accelerate response timeClaudia E Vickers, Paul S Freemont
Biochemical Society Transactions|December 3, 2016
Computational protein design with backbone plasticityJames T MacDonald, Paul S Freemont
Nature Biotechnology|April 12, 2017
With all due respect to Maholo, lab automation isn't anthropomorphicDavid W McClymont, Paul S Freemont
Current Opinion in Structural Biology|April 18, 2002
Machinery of protein folding and unfoldingXiaodong Zhang, Fabienne Beuron, Paul S Freemont
Current Biology : CB|April 5, 2003
SUMOThomas Sternsdorf, Kirsten Jensen, Paul S Freemont
Nucleic Acids Research|February 2, 2013
Validation of an entirely in vitro approach for rapid prototyping of DNA regulatory elements for synthetic biologyJames Chappell, Kirsten Jensen, Paul S Freemont
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Emerging Topics in Life Sciences|February 1, 2021
Synthetic biology industry: data-driven design is creating new opportunities in biotechnologyPaul S Freemont
The Biochemical Journal|August 19, 2017
The AAA+ ATPase p97, a cellular multitoolLasse Stach, Paul S Freemont
Synthetic Biology (Oxford, England)|October 29, 2021
Biofoundries are a nucleating hub for industrial translationTabasum Farzaneh, Paul S Freemont
GEN Biotechnology|January 16, 2023
Simple Low-Cost Production of DNA MS2 Virus-Like Particles As Molecular Diagnostic ControlsMichael A Crone, Paul S Freemont
Nature Communications|January 22, 2022
Pandemic preparedness: synthetic biology and publicly funded biofoundries can rapidly accelerate response timeClaudia E Vickers, Paul S Freemont
Biochemical Society Transactions|December 3, 2016
Computational protein design with backbone plasticityJames T MacDonald, Paul S Freemont
Nature Biotechnology|April 12, 2017
With all due respect to Maholo, lab automation isn't anthropomorphicDavid W McClymont, Paul S Freemont
Current Opinion in Structural Biology|April 18, 2002
Machinery of protein folding and unfoldingXiaodong Zhang, Fabienne Beuron, Paul S Freemont
Current Biology : CB|April 5, 2003
SUMOThomas Sternsdorf, Kirsten Jensen, Paul S Freemont
Nucleic Acids Research|February 2, 2013
Validation of an entirely in vitro approach for rapid prototyping of DNA regulatory elements for synthetic biologyJames Chappell, Kirsten Jensen, Paul S Freemont
Pageof 13